No Data
No Data
Flamingo Therapeutics Announces Poster Presentation at EACR 2024 Congress on FLM-7523 (FTX-001), a First-in-Class Inhibitor of the Long Non-Coding RNA MALAT1
LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA , June 10, 2024 /PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today announced a poster presentation on FLM-7523 (also referred to as FTX-0
TD Cowen Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $54
TD Cowen analyst Yaron Werber maintains $Ionis Pharmaceuticals(IONS.US)$ with a buy rating, and maintains the target price at $54.According to TipRanks data, the analyst has a success rate of 54.0% an
Express News | Ionis Pharmaceuticals Inc : JP Morgan Cuts Target Price to $50 From $55
Unusual Options Activity: IONS, NCLH and Others Attract Market Bets, IONS V/OI Ratio Reaches 318.7
EST Jun 4th Afternoon Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Express News | Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $60 Price Target
Ionis Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/03/2024 59.7% Needham $60 → $60 Reiterates Buy → Buy 05/08/2024 118.26% Wells Fargo $85 → $82 Maintains
No Data